A cancer-associated mutation in atypical protein kinase Cι occurs in a substrate-specific recruitment motif

Science Signaling

Volumn 6, Issue 293, 2013, Pages

  Linch, Mark ^a,b   Sanz Garcia, Marta ^a   Soriano, Erika ^a   Zhang, Yixiao ^a   Riou, Philippe ^a   Rosse, Carine ^a   Cameron, Angus ^a   Knowles, Phillip ^a   Purkiss, Andrew ^a   Kjaer, Svend ^a   McDonald, Neil Q ^a,c   Parker, Peter J ^a,d  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

^c UNIVERSITY OF LONDON   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LLGL2 PROTEIN; MYOSIN; PROTEIN KINASE C IOTA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CELL POLARITY; ENZYME SUBSTRATE COMPLEX; EPITHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; INTERVIEW; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; SIGNAL TRANSDUCTION;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; AMINO ACIDS, DIAMINO; ANALYSIS OF VARIANCE; ANIMALS; CELL POLARITY; CYTOSKELETAL PROTEINS; DOGS; HEK293 CELLS; HUMANS; IMMUNOBLOTTING; ISOENZYMES; MADIN DARBY CANINE KIDNEY CELLS; MASS SPECTROMETRY; MICROSCOPY, FLUORESCENCE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASM PROTEINS; PHOSPHORYLATION; PROTEIN CONFORMATION; PROTEIN KINASE C; SEQUENCE ALIGNMENT; SUBSTRATE SPECIFICITY;

EID: 84885770661     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2004068     Document Type: Article

References (74)

1. K. Akimoto, K. Mizuno, S. Osada, S. Hirai, S. Tanuma, K. Suzuki, S. Ohno, A new member of the third class in the protein kinase C family, PKCλ, expressed dominantly in an undifferentiated mouse embryonal carcinoma cell line and also in many tissues and cells. J. Biol. Chem. 269, 12677-12683 (1994).
2. G. Joberty, C. Petersen, L. Gao, I. G. Macara, The cell-polarity protein Par6 links Par3 and atypical protein kinase C to Cdc42. Nat. Cell Biol. 2, 531-539 (2000).
3. L. Sanz, P. Sanchez, M. J. Lallena, M. T. Diaz-Meco, J. Moscat, The interaction of p62 with RIP links the atypical PKCs to NF-κB activation. EMBO J. 18, 3044-3053 (1999).
4. A. Suzuki, M. Hirata, K. Kamimura, R. Maniwa, T. Yamanaka, K. Mizuno, M. Kishikawa, H. Hirose, Y. Amano, N. Izumi, Y. Miwa, S. Ohno, aPKC acts upstream of PAR-1b in both the establishment and maintenance of mammalian epithelial polarity. Curr. Biol. 14, 1425-1435 (2004).
5. A. M. Eder, X. Sui, D. G. Rosen, L. K. Nolden, K. W. Cheng, J. P. Lahad, M. Kango-Singh, K. H. Lu, C. L. Warneke, E. N. Atkinson, I. Bedrosian, K. Keyomarsi, W. L. Kuo, J. W. Gray, J. C. Yin, J. Liu, G. Halder, G. B. Mills, Atypical PKCι contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancer. Proc. Natl. Acad. Sci. U.S.A. 102, 12519-12524 (2005).
6. R. P. Regala, C. Weems, L. Jamieson, A. Khoor, E. S. Edell, C. M. Lohse, A. P. Fields, Atypical protein kinase Ci is an oncogene in human non-small cell lung cancer. Cancer Res. 65, 8905-8911 (2005).
7. Y. L. Yang, J. Y. Chu, M. L. Luo, Y. P.Wu, Y. Zhang, Y. B. Feng, Z. Z. Shi, X. Xu, Y. L. Han, Y. Cai, J. T. Dong, Q. M. Zhan, M. Wu, M. R. Wang, Amplification of PRKCI, located in 3q26, is associated with lymph node metastasis in esophageal squamous cell carcinoma. Genes Chromosomes Cancer 47, 127-136 (2008).
8. Y. Kojima, K. Akimoto, Y. Nagashima, H. Ishiguro, S. Shirai, T. Chishima, Y. Ichikawa, T. Ishikawa, T. Sasaki, Y. Kubota, Y. Inayama, I. Aoki, S. Ohno, H. Shimada, The overexpression and altered localization of the atypical protein kinase C λ/ι in breast cancer correlates with the pathologic type of these tumors. Hum. Pathol. 39, 824-831 (2008).
9. M. L. Scotti, W. R. Bamlet, T. C. Smyrk, A. P. Fields, N. R. Murray, Protein kinase Cι is required for pancreatic cancer cell transformed growth and tumorigenesis. Cancer Res. 70, 2064-2074 (2010).
10. R. Takagawa, K. Akimoto, Y. Ichikawa, H. Akiyama, Y. Kojima, H. Ishiguro, Y. Inayama, I. Aoki, C. Kunisaki, I. Endo, Y. Nagashima, S. Ohno, High expression of atypical protein kinase C l/i in gastric cancer as a prognostic factor for recurrence. Ann. Surg. Oncol. 17, 81-88 (2010).
11. Q. Li, J. M. Wang, C. Liu, B. L. Xiao, J. X. Lu, S. Q. Zou, Correlation of aPKC-iota and E-cadherin expression with invasion and prognosis of cholangiocarcinoma. Hepatobiliary Pancreat. Dis. Int. 7, 70-75 (2008).
12. R. Patel, H. Win, S. Desai, K. Patel, J. A. Matthews, M. Acevedo-Duncan, Involvement of PKC-i in glioma proliferation. Cell Prolif. 41, 122-135 (2008).
13. L. E. Dow, P. O. Humbert, Polarity regulators and the control of epithelial architecture, cell migration, and tumorigenesis. Int. Rev. Cytol. 262, 253-302 (2007).
14. M. Lisovsky, K. Dresser, S. Baker, A. Fisher, B. Woda, B. Banner, G. Y. Lauwers, Cell polarity protein Lgl2 is lost or aberrantly localized in gastric dysplasia and adenocarcinoma: An immunohistochemical study. Mod. Pathol. 22, 977-984 (2009).
15. H. B. Pearson, P. A. Perez-Mancera, L. E. Dow, A. Ryan, P. Tennstedt, D. Bogani, I. Elsum, A. Greenfield, D. A. Tuveson, R. Simon, P. O. Humbert, SCRIB expression is deregulated in human prostate cancer, and its deficiency in mice promotes prostate neoplasia. J. Clin. Invest. 121, 4257- 4267 (2011).
16. M. Lisovsky, K. Dresser, B. Woda, M. Mino-Kenudson, Immunohistochemistry for cell polarity protein lethal giant larvae 2 differentiates pancreatic intraepithelial neoplasia-3 and ductal adenocarcinoma of the pancreas from lower-grade pancreatic intraepithelial neoplasias. Hum. Pathol. 41, 902-909 (2010).
17. J. I. Partanen, T. A. Tervonen, M. Myllynen, E. Lind, M. Imai, P. Katajisto, G. J. Dijkgraaf, P. E. Kovanen, T. P. Mäkelä, Z. Werb, J. Klefström, Tumor suppressor function of Liver kinase B1 (Lkb1) is linked to regulation of epithelial integrity. Proc. Natl. Acad. Sci. U.S.A. 109, E388-E397 (2012).
18. S. Iden, W. E. van Riel, R. Schäfer, J. Y. Song, T. Hirose, S. Ohno, J. G. Collard, Tumor type-dependent function of the Par3 polarity protein in skin tumorigenesis. Cancer Cell 22, 389-403 (2012).
19. E. Erdogan, T. Lamark, M. Stallings-Mann, J. Lee, M. Pellecchia, E. A. Thompson, T. Johansen, A. P. Fields, Aurothiomalate inhibits transformed growth by targeting the PB1 domain of protein kinase Ci. J. Biol. Chem. 281, 28450-28459 (2006).
20. W. Guo, S. Wu, J. Liu, B. Fang, Identification of a small molecule with synthetic lethality for K-ras and protein kinase C iota. Cancer Res. 68, 7403-7408 (2008).
21. P. Pillai, S. Desai, R. Patel, M. Sajan, R. Farese, D. Ostrov, M. Acevedo-Duncan, A novel PKC-i inhibitor abrogates cell proliferation and induces apoptosis in neuroblastoma. Int. J. Biochem. Cell Biol. 43, 784-794 (2011).
22. Y. Izumi, T. Hirose, Y. Tamai, S. Hirai, Y. Nagashima, T. Fujimoto, Y. Tabuse, K. J. Kemphues, S. Ohno, An atypical PKC directly associates and colocalizes at the epithelial tight junction with ASIP, a mammalian homologue of Caenorhabditis elegans polarity protein PAR-3. J. Cell Biol. 143, 95-106 (1998).
23. C. Wang, Y. Shang, J. Yu, M. Zhang, Substrate recognition mechanism of atypical protein kinase Cs revealed by the structure of PKCι in complex with a substrate peptide from Par-3. Structure 20, 791-801 (2012).
24. T. J. Hung, K. J. Kemphues, PAR-6 is a conserved PDZ domain-containing protein that colocalizes with PAR-3 in Caenorhabditis elegans embryos. Development 126, 127-135 (1999).
25. P. J. Plant, J. P. Fawcett, D. C. Lin, A. D. Holdorf, K. Binns, S. Kulkarni, T. Pawson, A polarity complex of mPar-6 and atypical PKC binds, phosphorylates and regulates mammalian Lgl. Nat. Cell Biol. 5, 301-308 (2003).
26. T. Yamanaka, Y. Horikoshi, Y. Sugiyama, C. Ishiyama, A. Suzuki, T.Hirose, A. Iwamatsu, A. Shinohara, S. Ohno, Mammalian Lgl forms a protein complex with PAR-6 and aPKC independently of PAR-3 to regulate epithelial cell polarity. Curr. Biol. 13, 734-743 (2003).
27. J. Betschinger, K. Mechtler, J. A. Knoblich, The Par complex directs asymmetric cell division by phosphorylating the cytoskeletal protein Lgl. Nature 422, 326-330 (2003).
28. A. Hutterer, J. Betschinger, M. Petronczki, J. A. Knoblich, Sequential roles of Cdc42, Par-6, aPKC, and Lgl in the establishment of epithelial polarity during Drosophila embryogenesis. Dev. Cell 6, 845-854 (2004).
29. J. Betschinger, F. Eisenhaber, J. A. Knoblich, Phosphorylation-induced autoinhibition regulates the cytoskeletal protein Lethal (2) giant larvae. Curr. Biol. 15, 276-282 (2005).
30. K. Büther, C. Plaas, A. Barnekow, J. Kremerskothen, KIBRA is a novel substrate for protein kinase Cζ. Biochem. Biophys. Res. Commun. 317, 703-707 (2004).
31. J. B. Hurov, J. L. Watkins, H. Piwnica-Worms, Atypical PKC phosphorylates PAR-1 kinases to regulate localization and activity. Curr. Biol. 14, 736-741 (2004).
32. T. Ishiuchi, M. Takeichi, Willin and Par3 cooperatively regulate epithelial apical constriction through aPKC-mediated ROCK phosphorylation. Nat. Cell Biol. 13, 860-866 (2011).
33. Y. Yoshihama, Y. Izumisawa, K. Akimoto, Y. Satoh, T. Mizushima, K. Satoh, K. Chida, R. Takagawa, H. Akiyama, Y. Ichikawa, C. Kunisaki, Y. Inayama, I. Endo, Y. Nagashima, S. Ohno, High expression of KIBRA in low atypical protein kinase C-expressing gastric cancer correlates with lymphatic invasion and poor prognosis. Cancer Sci. 104, 259-265 (2013).
34. S. A. Lieser, B. E. Aubol, L. Wong, P. A. Jennings, J. A. Adams, Coupling phosphoryl transfer and substrate interactions in protein kinases. Biochim. Biophys. Acta 1754, 191-199 (2005).
35. R. M. Biondi, A. R. Nebreda, Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions. Biochem. J. 372, 1-13 (2003).
36. T. Tanoue, E. Nishida, Molecular recognitions in the MAP kinase cascades. Cell. Signal. 15, 455-462 (2003).
37. S. Kjær, M. Linch, A. Purkiss, B. Kostelecky, P. P. Knowles, C. Rosse, P. Riou, C. Soudy, S. Kaye, B. Patel, E. Soriano, J. Murray-Rust, C. Barton, C. Dillon, J. Roffey, P. J. Parker, N. Q. McDonald, Adenosine-binding motif mimicry and cellular effects of a thieno[2,3-d]pyrimidine-based chemical inhibitor of atypical protein kinase C isozymes. Biochem. J. 451, 329-342 (2013).
38. A. Messerschmidt, S. Macieira, M. Velarde, M. Bädeker, C. Benda, A. Jestel, H. Brandstetter, T. Neuefeind, M. Blaesse, Crystal structure of the catalytic domain of human atypical protein kinase C-iota reveals interaction mode of phosphorylation site in turn motif. J. Mol. Biol. 352, 918-931 (2005).
39. T. Takimura, K. Kamata, K. Fukasawa, H. Ohsawa, H. Komatani, T. Yoshizumi, I. Takahashi, H. Kotani, Y. Iwasawa, Structures of the PKC-ι kinase domain in its ATP-bound and apo forms reveal defined structures of residues 533-551 in the C-terminal tail and their roles in ATP binding. Acta Crystallogr. D Biol. Crystallogr. 66, 577-583 (2010).
40. X. Zhang, K. A. Pickin, R. Bose, N. Jura, P. A. Cole, J. Kuriyan, Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface. Nature 450, 741-744 (2007).
41. A. J. Cameron, C. Escribano, A. T. Saurin, B. Kostelecky, P. J. Parker, PKC maturation is promoted by nucleotide pocket occupation independently of intrinsic kinase activity. Nat. Struct. Mol. Biol. 16, 624-630 (2009).
42. N. Jura, N. F. Endres, K. Engel, S. Deindl, R. Das, M. H. Lamers, D. E.Wemmer, X. Zhang, J. Kuriyan, Mechanism for activation of the EGF receptor catalytic domain by the juxta-membrane segment. Cell 137, 1293-1307 (2009).
43. M. D. Resh, Myristylation and palmitylation of Src family members: The fats of the matter. Cell 76, 411-413 (1994).
44. D. Schaap, P. J. Parker, A. Bristol, R. Kriz, J. Knopf, Unique substrate specificity and regulatory properties of PKC- e: A rationale for diversity. FEBS Lett. 243, 351-357 (1989).
45. A. Suzuki, T. Yamanaka, T. Hirose, N. Manabe, K. Mizuno, M. Shimizu, K. Akimoto, Y. Izumi, T. Ohnishi, S. Ohno, Atypical protein kinase C is involved in the evolutionarily conserved par protein complex and plays a critical role in establishing epithelia-specific junctional structures. J. Cell Biol. 152, 1183-1196 (2001).
46. L. E. O'Brien, T. S. Jou, A. L. Pollack, Q. Zhang, S. H. Hansen, P. Yurchenco, K. E. Mostov, Rac1 orientates epithelial apical polarity through effects on basolateral laminin assembly. Nat. Cell Biol. 3, 831-838 (2001).
47. J. Debnath, J. S. Brugge, Modelling glandular epithelial cancers in three-dimensional cultures. Nat. Rev. Cancer 5, 675-688 (2005).
48. A. B. Jaffe, N. Kaji, J. Durgan, A. Hall, Cdc42 controls spindle orientation to position the apical surface during epithelial morphogenesis. J. Cell Biol. 183, 625-633 (2008).
49. J. Durgan, N. Kaji, D. Jin, A. Hall, Par6B and atypical PKC regulate mitotic spindle orientation during epithelial morphogenesis. J. Biol. Chem. 286, 12461-12474 (2011).
50. K. Shin, S. Straight, B. Margolis, PATJ regulates tight junction formation and polarity in mammalian epithelial cells. J. Cell Biol. 168, 705-711 (2005).
51. M. A. Schlüter, C. S. Pfarr, J. Pieczynski, E. L. Whiteman, T. W. Hurd, S. Fan, C. J. Liu, B. Margolis, Trafficking of Crumbs3 during cytokinesis is crucial for lumen formation. Mol. Biol. Cell 20, 4652-4663 (2009).
52. K. C. Liu, D. T. Jacobs, B. D. Dunn, A. S. Fanning, R. E. Cheney, Myosin-X functions in polarized epithelial cells. Mol. Biol. Cell 23, 1675-1687 (2012).
53. H. Zhang, J. S. Berg, Z. Li, Y. Wang, P. Lång, A. D. Sousa, A. Bhaskar, R. E. Cheney, S. Strömblad, Myosin-X provides a motor-based link between integrins and the cyto-skeleton. Nat. Cell Biol. 6, 523-531 (2004).
54. K. L. Weber, A. M. Sokac, J. S. Berg, R. E. Cheney, W. M. Bement, A microtubule-binding myosin required for nuclear anchoring and spindle assembly. Nature 431, 325-329 (2004).
55. J. Moscat, M. T. Diaz-Meco, A. Albert, S. Campuzano, Cell signaling and function organized by PB1 domain interactions. Mol. Cell 23, 631-640 (2006).
56. Cancer Genome Atlas Research Network, Integrated genomic analyses of ovarian carcinoma. Nature 474, 609-615 (2011).
57. T. Sjöblom, S. Jones, L. D. Wood, D. W. Parsons, J. Lin, T. D. Barber, D. Mandelker, R. J. Leary, J. Ptak, N. Silliman, S. Szabo, P. Buckhaults, C. Farrell, P.Meeh, S. D. Markowitz, J. Willis, D. Dawson, J. K. Willson, A. F. Gazdar, J. Hartigan, L. Wu, C. Liu, G. Parmigiani, B. H. Park, K. E. Bachman, N. Papadopoulos, B. Vogelstein, K. W. Kinzler, V. E. Velculescu, The consensus coding sequences of human breast and colorectal cancers. Science 314, 268-274 (2006).
58. C. House, P. J. Robinson, B. E. Kemp, A synthetic peptide analog of the putative substrate-binding motif activates protein kinase C. FEBS Lett. 249, 243-247 (1989).
59. M. Brajenovic, G. Joberty, B. Küster, T. Bouwmeester, G. Drewes, Comprehensive proteomic analysis of human Par protein complexes reveals an interconnected protein network. J. Biol. Chem. 279, 12804-12811 (2004).
60. L. M. Breshears, D. Wessels, D. R. Soll, M. A. Titus, An unconventional myosin required for cell polarization and chemotaxis. Proc. Natl. Acad. Sci. U.S.A. 107, 6918-6923 (2010).
61. K. Homma, J. Saito, R. Ikebe, M. Ikebe, Motor function and regulation of myosin X. J. Biol. Chem. 276, 34348-34354 (2001).
62. J. S. Berg, R. E. Cheney, Myosin-X is an unconventional myosin that undergoes intrafilopodial motility. Nat. Cell Biol. 4, 246-250 (2002).
63. T. M. Watanabe, H. Tokuo, K. Gonda, H. Higuchi, M. Ikebe, Myosin-X induces filopodia by multiple elongation mechanism. J. Biol. Chem. 285, 19605-19614 (2010).
64. F. Toyoshima, E. Nishida, Integrin-mediated adhesion orients the spindle parallel to the substratum in an EB1- and myosin X-dependent manner. EMBO J. 26, 1487-1498 (2007).
65. S. Woolner, L. L. O'Brien, C. Wiese, W. M. Bement, Myosin-10 and actin filaments are essential for mitotic spindle function. J. Cell Biol. 182, 77-88 (2008).
66. Y. Horikoshi, A. Suzuki, T. Yamanaka, K. Sasaki, K. Mizuno, H. Sawada, S. Yonemura, S. Ohno, Interaction between PAR-3 and the aPKC-PAR-6 complex is indispensable for apical domain development of epithelial cells. J. Cell Sci. 122, 1595-1606 (2009).
67. L. Huang, S. K. Muthuswamy, Polarity protein alterations in carcinoma: A focus on emerging roles for polarity regulators. Curr. Opin. Genet. Dev. 20, 41-50 (2010).
68. J. C. Pease, J. S. Tirnauer, Mitotic spindle misorientation in cancer - Out of alignment and into the fire. J. Cell Sci. 124, 1007-1016 (2011).
69. E. Gateff, H. A. Schneiderman, Neoplasms in mutant and cultured wild-type tissues of Drosophila. Natl. Cancer Inst. Monogr. 31, 365 -397 (1969).
70. C. C. Schimanski, G. Schmitz, A. Kashyap, A. K. Bosserhoff, F. Bataille, S. C. Schäfer, H. A. Lehr, M. R. Berger, P. R. Galle, S. Strand, D. Strand, Reduced expression of Hugl-1, the human homologue of Drosophila tumour suppressor gene lgl, contributes to progression of colorectal cancer. Oncogene 24, 3100-3109 (2005).
71. A. Kashyap, T. Zimmerman, N. Ergül, A. Bosserhoff, U. Hartman, V. Alla, F. Bataille, P. R. Galle, S. Strand, D. Strand, The human Lgl polarity gene, Hugl-2, induces MET and suppresses Snail tumorigenesis. Oncogene 32, 1396-1407 (2013).
72. X. Lu, X. Feng, X. Man, G. Yang, L. Tang, D. Du, F. Zhang, H. Yuan, Q. Huang, Z. Zhang, Y. Liu, D. Strand, Z. Chen, Aberrant splicing of Hugl-1 is associated with hepatocellular carcinoma progression. Clin. Cancer Res. 15, 3287-3296 (2009).
73. C. J. Hastie, H. J. McLauchlan, P. Cohen, Assay of protein kinases using radiolabeled ATP: A protocol. Nat. Protoc. 1, 968-971 (2006).
74. G. Manning, D. B. Whyte, R. Martinez, T. Hunter, S. Sudarsanam, The protein kinase complement of the human genome. Science 298, 1912-1934 (2002).